OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting epigenetic alterations in cancer stem cells
Francesco Verona, Vincenzo Davide Pantina, Chiara Modica, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 14
Francesco Verona, Vincenzo Davide Pantina, Chiara Modica, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 14
Showing 14 citing articles:
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells
Amirhosein Faghihkhorasani, Alaleh Dalvand, Ehsan Derafsh, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Amirhosein Faghihkhorasani, Alaleh Dalvand, Ehsan Derafsh, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Epigenetic Modulations in Breast Cancer: An Emerging Paradigm in Therapeutic Implications
Shilpi Sarkar, Dheepika Venkatesh, Thirukumaran Kandasamy, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 4
Shilpi Sarkar, Dheepika Venkatesh, Thirukumaran Kandasamy, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 4
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction
Francesco Verona, Sebastiano Di Bella, Roberto Schirano, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Francesco Verona, Sebastiano Di Bella, Roberto Schirano, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: the critical role of cyclin D
Yasin Ahmadi, Tahran Faiq, Sakhavat Abolhasani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Yasin Ahmadi, Tahran Faiq, Sakhavat Abolhasani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies
Azar Tahghighi, Effat Seyedhashemi, Javad Mohammadi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Azar Tahghighi, Effat Seyedhashemi, Javad Mohammadi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Common features between aging and cancer: a narrative review
Muhammad Abubakar, Yasir Hameed, Muhammad Kiani, et al.
Aging advances. (2024) Vol. 1, Iss. 2, pp. 118-134
Closed Access | Times Cited: 3
Muhammad Abubakar, Yasir Hameed, Muhammad Kiani, et al.
Aging advances. (2024) Vol. 1, Iss. 2, pp. 118-134
Closed Access | Times Cited: 3
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy
Melania Lo Iacono, Miriam Gaggianesi, Paola Bianca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6996-6996
Open Access | Times Cited: 9
Melania Lo Iacono, Miriam Gaggianesi, Paola Bianca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6996-6996
Open Access | Times Cited: 9
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment
Veronica Veschi, Alice Turdo, Giorgio Stassi
Frontiers in Molecular Medicine (2023) Vol. 3
Open Access | Times Cited: 4
Veronica Veschi, Alice Turdo, Giorgio Stassi
Frontiers in Molecular Medicine (2023) Vol. 3
Open Access | Times Cited: 4
Cancer stem cell, chromosomal instability, and cancer immunity
Laxmi Kumari, Saloni Munjal, Reena Yadav, et al.
Exploration of Immunology (2024), pp. 169-188
Open Access | Times Cited: 1
Laxmi Kumari, Saloni Munjal, Reena Yadav, et al.
Exploration of Immunology (2024), pp. 169-188
Open Access | Times Cited: 1
Cancer cell targeting by CAR-T cells: A matter of stemness
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 5
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane, et al.
Frontiers in Molecular Medicine (2022) Vol. 2
Open Access | Times Cited: 5
Involvement of epigenetic modifications in cancer stem cells and chemoresistance
Prajakta Oak, Chitra Thakur
Elsevier eBooks (2024), pp. 199-213
Closed Access
Prajakta Oak, Chitra Thakur
Elsevier eBooks (2024), pp. 199-213
Closed Access
Epigenetic modification: key regulator of reprogramming in cancer stem cells
Varsha Virendra Palol, Suresh Kumar Saravanan, Raj Kumar Chinnadurai, et al.
Elsevier eBooks (2023), pp. 227-242
Closed Access
Varsha Virendra Palol, Suresh Kumar Saravanan, Raj Kumar Chinnadurai, et al.
Elsevier eBooks (2023), pp. 227-242
Closed Access
